10849919

Cases: 5
Active: 0; 5 closed
Filed: 2022–2023
Top venue: D Del; 4 cases

Filing activity

Cases asserting US Patent 10849919 filed per year.

Merck KGaA et al. v. Hopewell Pharma Ventures, Inc. et al.

stayed

Docket:: 1:22-cv-01365-GBW-CJB
Court:: D. Del.
Filed:: 2022-10-17

π Merck KGaA π Merck Serono SA π Ares Trading SA Δ Hopewell Pharma Ventures, Inc.Δ Aurobindo Pharma USA, Inc.Δ Aurobindo Pharma Ltd.Δ Apotex Inc.Δ Apotex Corp.

Original complaint asserted '919; plaintiffs ceased asserting the '919 patent against all defendants. The consolidated case was later globally stayed pending IPR appeals on the '947 and '903 patents.

Merck KGaA et al. v. Accord Healthcare, Inc.

stayed

Docket:: 1:22-cv-00974-GBW
Court:: D. Del.
Filed:: 2022-07-25

Patents:10849919 7713947 8377903

π Merck KGaA π Merck Serono SA π Ares Trading SA Δ Accord Healthcare, Inc.

First Amended Complaint (ANDA No. 216813) asserted the '947, '903, and '919 patents. The case was stayed within the same global stay; there was no separate '919 outcome.

Merck KGaA et al. v. Aurobindo Pharma USA, Inc. et al.

consolidated

Docket:: 1:23-cv-00039-GBW-CJB
Court:: D. Del.

Patents:10849919 7713947 8377903

π Merck KGaA π Merck Serono SA π Ares Trading SA Δ Aurobindo Pharma USA, Inc.Δ Aurobindo Pharma Ltd.

Consolidated into 22-1365. The '919 patent was asserted in the original complaint but dropped; the consolidated case involved the '947 and '903 patents.

Merck KGaA et al. v. Apotex Inc. et al.

consolidated

Docket:: 1:23-cv-00655-GBW-CJB
Court:: D. Del.

Patents:10849919 7713947 8377903

π Merck KGaA π Merck Serono SA π Ares Trading SA Δ Apotex Inc.Δ Apotex Corp.

Consolidated into 22-1365 (except trial). The '919 patent was asserted in the original complaint but dropped; Apotex's ANDA was approved Nov. 24, 2025. The consolidated case involved the '947 and '903 patents.

Hopewell Pharma Ventures, Inc. v. Ares Trading SA

settled

Docket:: IPR2023-00482
Court:: PTAB
Filed:: 2023-02-10
Terminated:: 2023-08-16

Patents:10849919

π Hopewell Pharma Ventures, Inc.Δ Ares Trading SA

PTAB IPR petition challenging claims 1–6, 8–9, 11–12, 14–16, 18–20, 23–27, 30, and 33–34 of US 10,849,919. Terminated-settled before a final written decision.